Live feed06:00:00·723dPRReleasevia QuantisnowAC Immune and Takeda Sign Exclusive Option and License Agreement for Active Immunotherapy Targeting Amyloid Beta for Alzheimer's DiseaseByQuantisnow·Wall Street's wire, on your screen.ACIU· AC Immune SATAK· Takeda Pharmaceutical Company LimitedHealth Care